My point is that the most relevant data Imugene considers useful is the 15% which Leslie has mentioned in email to a shareholder can’t remember to whom.
The other data isn’t safer as it’s not apples for apples, again that’s IMU’s viewpoint from emails we’ve received. Disagree as you like with that but I wouldn’t mock people for that view point. ie agreeing with the actual scientists.
One could easily form the view that as the dose escalates those rates of pseudoprogression might fall in line with similar therapy. Which CF33 has outperformed preclinically (TVec) not unreasonable to expect newer therapies to potentially go a step further as well..
We are still waiting to see.
- Forums
- ASX - By Stock
- Ann: Imugene Presentation to Bell Potter Conference
My point is that the most relevant data Imugene considers useful...
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M |
Open | High | Low | Value | Volume |
5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 1854997 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 382882 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 1694499 | 0.052 |
37 | 4870470 | 0.051 |
51 | 4160179 | 0.050 |
17 | 2263068 | 0.049 |
19 | 954663 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 282882 | 3 |
0.054 | 2751851 | 4 |
0.055 | 1611272 | 15 |
0.056 | 2792035 | 11 |
0.057 | 700330 | 7 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |